Solitary cysticercus granuloma-treatment with albendazole: what is the optimal duration?
Singh
Gagandeep
G
Murthy
J M K
JM
D015766:Albendazole / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D003551:Cysticercosis / Q000150:complications* / Q000188:drug therapy; D006099:Granuloma / Q000150:complications* / Q000188:drug therapy* / Q000469:parasitology; D006801:Humans
D000981:Antiprotozoal Agents; D015766:Albendazole